Alphinat Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Alphinat prevailing Real Value cannot be determined due to lack of data. The current price of Alphinat is $0.0. Our model approximates the value of Alphinat from analyzing the firm fundamentals such as Return On Asset of 0.0632, shares outstanding of 63.15 M, and Operating Margin of 0.04 % as well as examining its technical indicators and probability of bankruptcy.

Alphinat Total Value Analysis

Alphinat is presently anticipated to have takeover price of 2.45 M with market capitalization of 3.79 M, debt of 47.53 K, and cash on hands of 43.01 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Alphinat fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
2.45 M
3.79 M
47.53 K
43.01 K

Alphinat Investor Information

About 29.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Based on the key indicators related to Alphinat's liquidity, profitability, solvency, and operating efficiency, Alphinat is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.

Alphinat Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Alphinat has an asset utilization ratio of 261.63 percent. This implies that the Company is making $2.62 for each dollar of assets. An increasing asset utilization means that Alphinat is more efficient with each dollar of assets it utilizes for everyday operations.

Alphinat Ownership Allocation

Alphinat holds a total of 63.15 Million outstanding shares. Alphinat retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Alphinat Profitability Analysis

The company reported the revenue of 1.65 M. Net Income was 112.75 K with profit before overhead, payroll, taxes, and interest of 253.34 K.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Alphinat's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Alphinat and how it compares across the competition.

Alphinat Growth Indicators

Investing in growth stocks can be very risky. If the company such as Alphinat does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding63.1 M
Quarterly Earnings Growth Y O Y-0.919
Retained Earnings-9.4 M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in Alphinat Pink Sheet

If you are still planning to invest in Alphinat check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alphinat's history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Managers
Screen money managers from public funds and ETFs managed around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals